Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Business

Johnson & Johnson Plans to Sell Prescription Drugs to TrumpRx in Cost-Reduction Push

The Johnson & Johnson logo is displayed at company offices on October 17, 2023 in Irvine, California. Johnson & Johnson beat Wall Street’s quarterly revenue and earnings estimates as sales in its pharmaceutical and medical devices businesses grew.

Pharmaceutical giant Johnson & Johnson is set to sell several of its prescription medications through the TrumpRx platform, a US government-linked website designed to lower drug prices for patients.

The move is part of a broader cost-cutting agreement between major drugmakers and the Trump administration aimed at making medicines more affordable.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.